dc.description.abstract | The pharmaceutical industry plays a crucial role in providing essential
healthcare products and services, and its success heavily relies on effective
promotional strategies. This thesis paper investigates the insight of corporate
social responsibility on BRAC bank limited. The study aims to analyze the
promotional techniques and their impact on the market performance of these
companies. To achieve the objectives, a comprehensive literature review was
conducted, encompassing various aspects of pharmaceutical promotional
strategies and their significance in the context of the Bangladeshi market. The
research methodology employed a mixed-method approach, incorporating
both qualitative and quantitative techniques. Primary data were gathered
through interviews with key personnel from BRAC bank limited and Square
Pharmaceuticals, while secondary data were collected from company reports,
industry publications, and relevant academic sources. The analysis of market
performance indicators demonstrated a positive correlation between effective
promotional strategies and business growth. BRAC bank limited and Square
Pharmaceuticals witnessed significant increases in market share, brand
recognition, and sales revenue, indicating the effectiveness of their
promotional initiatives. The study also identified specific challenges faced by
the companies in implementing their promotional strategies, such as
regulatory constraints, competitive pressures, and changing customer
preferences. Overall, this thesis contributes to the understanding of
promotional strategies in the pharmaceutical industry, particularly in the
context of Bangladesh. The research highlights the importance of tailored
promotional approaches and the integration of traditional and digital
marketing methods to effectively reach healthcare professionals and
consumers. The findings can serve as a valuable resource for pharmaceutical
companies, marketing professionals, and policymakers to enhance their
promotional efforts and drive sustainable growth in the pharmaceutical sector
of Bangladesh.
vii | en_US |